Requirement for T-cell apoptosis in the induction of peripheral transplantation tolerance

被引:485
作者
Wells, AD
Li, XC
Li, YS
Walsh, MC
Zheng, XX
Wu, ZH
Nuñez, G
Tang, AM
Sayegh, M
Hancock, WW
Strom, TB
Turka, LA [1 ]
机构
[1] Univ Penn, Dept Med, Philadelphia, PA 19104 USA
[2] Harvard Univ, Sch Med, Dept Med, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[3] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA
[4] Harvard Univ, Sch Med, Dept Pathol, Cambridge, MA 02142 USA
[5] LeukoSite Inc, Cambridge, MA 02142 USA
[6] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med, Boston, MA 02115 USA
关键词
D O I
10.1038/15260
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The mechanisms of allograft tolerance have been classified as deletion, anergy, ignorance and suppression/regulation. Deletion has been implicated in central tolerance(1), whereas peripheral tolerance has generally been ascribed to clonal anergy and/or active immunoregulatory states(2). Here, we used two distinct systems to assess the requirement for T-cell deletion in peripheral tolerance induction. in mice transgenic for Bcl-x(L), T cells were resistant to passive cell death through cytokine withdrawal, whereas T cells from interleukin-2-deficient mice did not undergo activation-induced cell death. Using either agents that block co-stimulatory pathways or the immunosuppressive drug rapamycin, which we have shown here blocks the proliferative component of interleukin-2 signaling but does not inhibit priming for activation-induced cell death, we found that mice with defective passive or active T-cell apoptotic pathways were resistant to induction of transplantation tolerance. Thus, deletion of activated T cells through activation-induced cell death or growth factor withdrawal seems necessary to achieve peripheral tolerance across major histocompatibility complex barriers.
引用
收藏
页码:1303 / 1307
页数:5
相关论文
共 24 条
  • [11] Li XC, 1998, J IMMUNOL, V161, P2241
  • [12] INDUCTION BY ANTIGEN OF INTRATHYMIC APOPTOSIS OF CD4+CD8+TCRLO THYMOCYTES INVIVO
    MURPHY, KM
    HEIMBERGER, AB
    LOH, DY
    [J]. SCIENCE, 1990, 250 (4988) : 1720 - 1723
  • [13] The cell death inhibitor Bcl-2 and its homologues influence control of cell cycle entry
    OReilly, LA
    Huang, DCS
    Strasser, A
    [J]. EMBO JOURNAL, 1996, 15 (24) : 6979 - 6990
  • [14] SURVIVAL OF MOUSE PANCREATIC-ISLET ALLOGRAFTS IN RECIPIENTS TREATED WITH ALLOGENEIC SMALL LYMPHOCYTES AND ANTIBODY TO CD40 LIGAND
    PARKER, DC
    GREINER, DL
    PHILLIPS, NE
    APPEL, MC
    STEELE, AW
    DURIE, FH
    NOELLE, RJ
    MORDES, JP
    ROSSINI, AA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (21) : 9560 - 9564
  • [15] RAPAMYCIN-INDUCED INHIBITION OF THE 70-KILODALTON S6 PROTEIN-KINASE
    PRICE, DJ
    GROVE, JR
    CALVO, V
    AVRUCH, J
    BIERER, BE
    [J]. SCIENCE, 1992, 257 (5072) : 973 - 977
  • [16] CD28-B7 BLOCKADE AFTER ALLOANTIGENIC CHALLENGE IN-VIVO INHIBITS TH1 CYTOKINES BUT SPARES TH2
    SAYEGH, MH
    AKALIN, E
    HANCOCK, WW
    RUSSELL, ME
    CARPENTER, CB
    LINSLEY, PS
    TURKA, LA
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (05) : 1869 - 1874
  • [17] ACQUISITION OF IMMUNOLOGICAL SELF-TOLERANCE
    SCHWARTZ, RH
    [J]. CELL, 1989, 57 (07) : 1073 - 1081
  • [18] Sykes M, 1990, Semin Immunol, V2, P401
  • [19] Modifications of CD8+ T cell function during in vivo memory or tolerance induction
    Tanchot, C
    Guillaume, S
    Delon, J
    Bourgeois, C
    Franzke, A
    Sarukhan, A
    Trautmann, A
    Rocha, B
    [J]. IMMUNITY, 1998, 8 (05) : 581 - 590
  • [20] Tran HM, 1997, J IMMUNOL, V159, P2232